Are you looking to improve the performance of your peptide drug products? Register to attend today and walk away with game-changing development strategies which could decrease time-to-market and save you millions. The 2021 Peptide Drug Design & Delivery Summit will bring together key decision-makers and innovators within this rapidly growing field. This intensive 2-Day program...
How can you ramp up your new employee experience by implementing inclusive onboarding and transition practices at your organization? Join Slone Partners and Biocom California for a timely interactive discussion where we will share best practices and tangible tools to help your organization develop an inclusive experience to onboard and retain top talent. The extent...
Join Biocom California and the City of Fremont on July 21st to hear from a panel of industry leaders on why life science is booming in Fremont, initiatives to recruit local talent, the industry's evolution, and how companies in Fremont will contribute to future life science growth in the Bay Area.
DGE invites you to its inaugural Chief Patient Officer Summit – the only industry event to specifically focus on opportunities and challenges facing Chief Patient Officers and executives focused on building the best possible patient experience. From identifying unmet patient needs in discovery research… to accelerating greater diversity and inclusion in clinical trials… to ensuring...
For decades now, X-ray crystallography has been the go-to technique to unravel structural details of proteins, in pursuit of answering various biological questions and aiding structure based drug design. However, in the last few years, cryo-Electron Microscopy (cryoEM) has garnered a lot of attention and is quickly advancing towards being the most effective and powerful...
Join us for a unique networking event, which is free of charge, to watch ‘Shark-Tank’ style pitches from three new startup companies located at the Pennsylvania Biotechnology Center (PABC), followed by breakout sessions for each company. The three companies are: (1) EcoGenome, a life science company dedicated to the development of prognostic and predictive tests...
In 2021, Berkeley Lab's 90th year, we're celebrating past achievements and imagining tomorrow's solutions. As part of this celebration we are highlighting our facilities like never before! In this pre-scheduled, live, interactive, presentation by Lab staff and scientists you will learn about the Joint Genome Institute. The mission of the U.S. Department of Energy (DOE) Joint Genome...
Miss being able to network with colleagues in the life science industry? We have you covered with the best virtual networking experience through Grapevine Network's networking platform. Connect with life science colleagues from all over the world. BioXchange has gone virtual to allow the best online opportunity to interact with individuals from throughout the life...
This lung therapeutic symposium intends to bring advancement and cross-functional collaboration at the interface of discovery and development in the inhalation space. The symposium will give insight into the underlying biology of lung targets, which may open potential avenues for new biomarkers and respiratory therapeutics. It will also outline the differences in pharmacokinetic and in-vitro...
Join Biocom California, LA for a conversation with life science entrepreneurs, investors, and thought leaders from the Pasadena and San Gabriel Valley area as we highlight bioscience innovation, economic and research developments and expansion in this important ‘microcluster.’ Speakers: Opening Remarks – Senator Anthony Portantino, of the 25th Senate District Panel Discussion – Andreas Gille,...
Join us for this FREE, virtual event! Randall Hyer, MD, PhD, MPH Senior Vice President at Moderna Therapeutics, Inc. will be presenting on the topic "The Beginning and End of COVID-19." This event is free of charge but pre-registration is required.
Non-dilutive funding refers to financing that does not require selling or giving away equity to raise capital. Therefore, it does not result in the dilution of the existing company owners. Examples include commercial loans, profit-sharing arrangements, foundation grants, and government SBIR & STTR grants. This meeting will focus primarily on the latter type of non-dilutive...
